Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abbott | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Abbott

Pharma revenues for 3Q09 were $4.1 billion, a 2% drop from last year.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott 3Q09

3Q Revenues: $7.8 billion (+4%)

3Q Earnings: $1.5 billion (+37%)

YTD Revenues: $22.0 billion (+2%)

YTD Earnings: $4.2 billion (+26%)

Comments: Pharma revenues for 3Q09 were $4.1 billion, a 2% drop from last year. Currency fluctuation accounted for a 6% shortfall. Pharma sales for YTD were $11.6 billion, down 4% (with a 7% hit from currency). Pharma sales were led by Humira, which posted sales of $1.5 billion (+24%) in 3Q09 and $3.8 billion (+21%) YTD. Depakote sales plummeted due to generic competition, falling 71% to $92 million in 3Q09 and $324 million YTD. Earnings this quarter got a boost from a favorable patent settlement for a stent.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters